(RTTNews) - Humacyte, Inc. (HUMA), a biotechnology company, Tuesday announced its plan to file an Investigational New Drug or IND application with the U.S. FDA in 2025 to support a first-in-human ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback